Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00440492 · ClinicalTrials.gov registry record · Phase 1
Study To Evaluate The Pharmacokinetic Interaction Between PLA-695 And Methotrexate In Adults With Rheumatoid Arthritis
A Phase 1 study of Arthritis, Rheumatoid, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Study locations
NCT00440492: Completed Phase 1 study of Arthritis, Rheumatoid, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
NCT00440492 is a Phase 1 study of Arthritis, Rheumatoid that has completed, run by Wyeth is now a wholly owned subsidiary of Pfizer. The trial reports 9 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00440492, a Phase 1 study of Arthritis, Rheumatoid, has completed, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9
- Study locations
Study Summary
The purpose of this study is to determine if PLA-695 changes the blood concentrations of methotrexate when administered together.
Conditions Studied
Interventions
- DRUG PLA-695
Study Locations (9)
California
- - Los Angeles
- - Palo Alto
New York
- - Lake Success
- - Rochester
North Carolina
- - Charlotte
Ohio
- - Columbus
British Columbia
- - Vancouver
Ontario
- - Mississauga
Quebec
- - Montreal
Trial Details
| Field | Value |
|---|---|
| Start Date | 2006-12 |
| Est. Completion | 2007-11 |
| Phase | Phase 1 |
What the finished NCT00440492 record still lists
NCT00440492 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Arthritis, Rheumatoid appearing as the primary indexed condition, and to 1 intervention - of which PLA-695 is the first listed.
NCT00440492 lists 9 locations in 7 states (California, New York, North Carolina).
Frequently Asked Questions
What is clinical trial NCT00440492 about?
NCT00440492 is a clinical study titled "Study To Evaluate The Pharmacokinetic Interaction Between PLA-695 And Methotrexate In Adults With Rheumatoid Arthritis". The purpose of this study is to determine if PLA-695 changes the blood concentrations of methotrexate when administered together.
What is the current status of trial NCT00440492?
This trial is currently completed. It is a Phase 1 study. The study started on 2006-12. Estimated completion is 2007-11.
What conditions does trial NCT00440492 study?
This clinical trial studies the following conditions: Arthritis, Rheumatoid.
What interventions are being tested in trial NCT00440492?
The interventions under investigation include: PLA-695 (DRUG).
Who is sponsoring clinical trial NCT00440492?
This trial is sponsored by Wyeth is now a wholly owned subsidiary of Pfizer, which has 167 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00440492 being conducted?
This trial has 9 study locations across California, New York, North Carolina, Ohio, British Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthritis, Rheumatoid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
R-2487 in Patients With Rheumatoid Arthritis
RECRUITING · Phase 1
-
6-Month Phase I/II Open Label PRTX-100 in Previous Rheumatoid Arthritis Study Participants and Sera Collection
COMPLETED · Phase 1
-
A Safety and Pharmacokinetics Study in Participants With Rheumatoid Arthritis
COMPLETED · Phase 1
-
Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA
COMPLETED · Phase 1
-
Chronic Pain in Rheumatoid Arthritis
RECRUITING
-
IMPACT - AndHealth Autoimmune Research Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia